Articulinx offers minimally-invasive implants and devices for the treatment of hand osteoarthritis. The Company’s products are also used in the orthopedic, extremities and small joints market. Articulinx' first product ICMC offers a less-invasive early-stage alternative to chronic drug therapies and irreversible joint-replacement surgeries.